Quadratus Lumborum Block III Versus Peritubal Local Infiltration

Investigators compare post operative analgesic efficacy of peritubal local infiltration versus Quadratus Lumborum Block III . In patients undergoing Percutaneous Nephrolithotomy operation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Pain Neurologic Manifestations Pain Pain, Postoperative Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

21 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ain Shams University hosptal

Cairo, Abbasya, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient with pelvic renal stone less than 2 cm
Americans society of Anesthesiologists physical status I, II
BMI<35

Exclusion criteria

patient refusal to participate in the study
Americans society of Anesthesiologists physical status III or above
major hepatic, renal or cardiovascular disease
BMI > 35
coagulopathy
psychological disorders.

Treatment and study plan

Quadratus block versus peritubal local infiltration

Procedure

Quadratus lumborum block III versus peritubal local infiltration in patients undergoing Percutaneous Nephrolithotomy operation

Primary outcomes

Postoperative analgesia

Time frame: 24 hours

Postoperative pain measured by visual analogue scale from 0 to 10 measured over 24h where 0 is better and 10 means worst pain
Analgesic requirement

Time frame: 24 hours

Investigators measured the total dose of morphine consumption in mg over 24hour

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Postoperative Analgesic Efficiency of Quadratus Lumborum Block III Versus Peritubal Local Infiltration in Patients Undergoing exPercutaneous Percutaneous Nephrolithotomy Operation : a Randomized Comparative Study

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Jan 2, 2020
Registry last updated: Nov 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed